May 28, 2020
On May 27, VDP temporarily revised the preferred drug list to address reported possible drug shortages of products in the Platelet Aggregation Inhibitors drug class. The change allows providers to prescribe these drugs without requiring a non-preferred prior authorization and people enrolled in Medicaid continued access to necessary medication. A list of the affected drugs is below. This is a temporary change until the preferred products are sufficiently available in the market.
Contact email@example.com with questions or for more information.
|43598033960||ASPIRIN-DIPYRIDAM ER 25-200 MG|
|49884000702||ASPIRIN-DIPYRIDAM ER 25-200 MG|
|62559085060||ASPIRIN-DIPYRIDAM ER 25-200 MG|
|65162059606||ASPIRIN-DIPYRIDAM ER 25-200 MG|
|70436009205||ASPIRIN-DIPYRIDAM ER 25-200 MG|
|68462040560||ASPIRIN-DIPYRIDAM ER 25-200 MG|